Recruitment
CATALYST is now closed to recruitment. Patients were recruited nationwise to three treatment arms, with 12 particiapting sites.
Ensuring ethnic diversity in COVID-19 research
In the UK, people from all minority ethnic groups (apart from Chinese and Mixed-race groups) are at greater risk of becoming severely ill with COVID-19 when compared to the White population. In particular, Black men and women are nearly twice as likely as white people to die from COVID-19. Therefore, it is imperative that members of minority ethnic groups are included in COVID-19 research.
To help researchers ensure ethnic diversity in COVID-19 research, the NIHR has provided resources which can be found here.
Participating sites
The following hospitals were open to recruitment to the CATALYST trial:
Birmingham
Queen Elizabeth Hospital
Heartlands Hospital
Good Hope Hospital
Cardiff
University Hospital of Wales
London
Charing Cross Hospital
Hammersmith Hospital
St Mary's Hospital
University College Hospital
Swansea
Swansea Bay University Health Board Hospitals
Sheffield
Sheffield Teaching Hospitals